https://www.selleckchem.com/pr....oducts/nazartinib-eg
The aim of this study was to determine the incidence of steroid-induced hyperglycaemia (SIH) in patients hospitalised at the tertiary centre for lung diseases, to assess glycaemic control during hospitalisation, and to determine the factors associated with the control of SIH. A 4-month retrospective study was conducted. All patients who received systemic glucocorticoids for ≥ 2days during hospitalisation, with ≥ 2 elevated blood glucose (BG) readings, were included in the analysis. SIH control was determined by mean BG
Like
Comment
Share
